• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Asia Pacific Insomnia Market

    ID: MRFR/Pharma/0176-HCR
    50 Pages
    Kinjoll Dey
    October 2025

    Asia Pacific Insomnia Market Research Report, By Types Of Therapy (Pharmacological Therapy And Non-Pharmacological Therapy), By Drug Formulation (Capsules, Tablet And Others), By Type Of Diseases (Poor Quality Of Sleep, Sleep Maintenance And Other) - Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Asia Pacific Insomnia Market Infographic
    Purchase Options

    Asia Pacific Insomnia Market Summary

    As per Market Research Future Analysis, the Asia Pacific Insomnia Market was valued at USD 0.14 Billion in 2023 and is projected to grow to USD 0.20 Billion by 2032, with a CAGR of 8.12% from 2024 to 2032. Insomnia, the most prevalent sleep disorder, affects a significant portion of the population, particularly women and younger individuals. Factors such as increased alcohol, caffeine, and tobacco consumption, along with psychological and behavioral issues, are driving the rise in insomnia cases. The market is further supported by technological advancements and rising healthcare expenditures. However, a lack of education and awareness may hinder growth.

    Key Market Trends & Highlights

    The Asia Pacific Insomnia Market is witnessing significant growth driven by various factors.

    • Market Size in 2023: USD 0.14 Billion
    • Projected Market Size by 2032: USD 0.20 Billion
    • CAGR from 2024 to 2032: 8.12%
    • Japan holds the largest market share, with 1 in 5 people affected by insomnia.

    Market Size & Forecast

    2023 Market Size USD 0.14 Billion
    2024 Market Size USD 0.18 Billion
    2032 Market Size USD 0.20 Billion

    Major Players

    Key players include Takeda Pharmaceutical Company, Pfizer, Inc., Eisai, Co., Merck & Co Inc, Sanofi, and GlaxoSmithKline Plc.

    Key Companies in the Asia Pacific Insomnia Market market include

    Market Segmentation

    Asia Pacific Insomnia Market Segmentation

    Asia Pacific Insomnia Market Intended Audience
    • Manufacturing and packaging industries
    • Insomnia devices and drug manufacturers
    • Insomnia devices and drug suppliers
    • Biotechnology Companies
    • Bio-Pharmaceutical Companies
    • Research and Development (R&D) Companies
    • Government Research Laboratories
    • {" "=>[]}

    Report Scope

    Attribute/Metric Details
    Market Size USD 0.20 Billion by 2032
    CAGR 8.12% (2024-2032)
    Base Year   2023
    Forecast Period   2024-2032
    Historical Data   2021
    Forecast Units   Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Types, end user, Region
    Geographies Covered Asia Pacific
    Key Vendors Takeda Pharmaceutical Company (Japan), Pfizer, Inc. (US), Eisai, Co. (Japan),  Merck & Co Inc (US), Sanofi (France),  GlaxoSmithKline Plc. (UK), Meda Consumer Healthcare Inc (US), Care Fusion Corporation (US), Pernix Therapeutics (US), Purdue Pharma L.P. (US), Consumer Healthcare Inc. (Canada), Dainippon Sumitomo (Japan), ECR Pharmaceuticals (US), Johnson & Johnson (US),  Astellas (UK), Biocodex S A (France), Neurim (Switzerland), Flynn Pharma (UK)

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment
    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials